PharVision Advisers’s Marathon Petroleum MPC Stock Holding History

PharVision Advisers’s Portfolio MPC Stock Details MPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,924	Closed	-$313K	–	439
2025 Q4	$313K	Buy	+1,924	New	+$360K	0.16%	247

Other funds holding MPC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's MPC Position: Q1 2026 in Review

PharVision Advisers sold out of Marathon Petroleum (MPC) in Q1 2026, closing a stake of 1,924 shares — an estimated $313K sold.

PharVision Advisers first reported a position in MPC in Q4 2025 and held it in 1 quarter. The position peaked at $313K in Q4 2025. 1,882 funds tracked by Wall St. Rank hold MPC as of Q1 2026.

PharVision Advisers reported no remaining Marathon Petroleum position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,924 Marathon Petroleum shares in Q1 2026, an estimated $313K.
PharVision Advisers first reported a position in Marathon Petroleum in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Marathon Petroleum position peaked at $313K in Q4 2025.
1,882 funds tracked by Wall St. Rank held Marathon Petroleum as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.